Maywufa Company Ltd. (1731.TW)

TWD 22.25

(0.23%)

Operating Income Summary of Maywufa Company Ltd.

  • Maywufa Company Ltd.'s latest annual operating income in 2023 was 211.01 Million TWD , up 0.36% from previous year.
  • Maywufa Company Ltd.'s latest quarterly operating income in 2024 Q2 was 50.51 Million TWD , down -30.7% from previous quarter.
  • Maywufa Company Ltd. reported an annual operating income of 210.26 Million TWD in 2022, down -2.86% from previous year.
  • Maywufa Company Ltd. reported an annual operating income of 216.44 Million TWD in 2021, up 20.64% from previous year.
  • Maywufa Company Ltd. reported a quarterly operating income of 72.89 Million TWD for 2024 Q1, up 90.48% from previous quarter.
  • Maywufa Company Ltd. reported a quarterly operating income of 54.99 Million TWD for 2023 Q2, down -18.98% from previous quarter.

Annual Operating Income Chart of Maywufa Company Ltd. (2023 - 2009)

Historical Annual Operating Income of Maywufa Company Ltd. (2023 - 2009)

Year Operating Income Operating Income Growth
2023 211.01 Million TWD 0.36%
2022 210.26 Million TWD -2.86%
2021 216.44 Million TWD 20.64%
2020 179.41 Million TWD 28.16%
2019 139.99 Million TWD 1.76%
2018 137.56 Million TWD -13.47%
2017 158.99 Million TWD 24.72%
2016 127.47 Million TWD 12.75%
2015 113.05 Million TWD 48.47%
2014 76.14 Million TWD 0.78%
2013 75.55 Million TWD 18.66%
2012 63.67 Million TWD 168.96%
2011 23.67 Million TWD -25.87%
2010 31.93 Million TWD 149.09%
2009 12.82 Million TWD 0.0%

Peer Operating Income Comparison of Maywufa Company Ltd.

Name Operating Income Operating Income Difference
Grape King Bio Ltd 2.49 Billion TWD 91.548%
Standard Chem & Pharm CO., LTD. 1.25 Billion TWD 83.247%
ScinoPharm Taiwan, Ltd. 314.49 Million TWD 32.901%
Lotus Pharmaceutical Co., Ltd. 4.9 Billion TWD 95.696%
LIWANLI Innovation Co., Ltd. - TWD -Infinity%
YungShin Global Holding Corporation 929.61 Million TWD 77.3%
PhytoHealth Corporation -121.67 Million TWD 273.426%
SCI Pharmtech, Inc. 160.3 Million TWD -31.64%
Formosa Laboratories, Inc. 674.97 Million TWD 68.737%
PharmaEssentia Corporation - TWD -Infinity%
Bora Pharmaceuticals Co., LTD. 5.24 Billion TWD 95.98%